Service d'Endocrinologie, CHU de Nantes, Boulevard Jacques Monod, 44093, Nantes Cedex 1, France.
Clinique de Chirurgie Digestive et Endocrinienne, CHU de Nantes, Hôtel Dieu, Place Ricordeau, 44093, Nantes Cedex 1, France.
Langenbecks Arch Surg. 2019 Jun;404(4):431-438. doi: 10.1007/s00423-019-01782-1. Epub 2019 Apr 6.
Mild primary hyperparathyroidism (serum calcium ≤ 2.85 mmol/L) is the most representative form of pHPT nowadays. The aim of this study was to evaluate its subtypes and the multiglandular disease (MGD) rate as it may lower the sensitivity of preoperative parathyroid scintigraphy and the surgical cure rate.
We retrospectively included patients with mild pHPT who underwent parathyroid dual-tracer scintigraphy with Tc-MIBI SPECT/CT and surgery between January 2013 and December 2015. Cure was defined as normalization of serum calcium (or PTH in the normocalcemic form) at 6 months. MGD was defined by either two abnormal resected glands or persistent disease after resection of at least one abnormal gland.
We included 121 patients. Median preoperative serum calcium was 2.68 mmol/L and median PTH was 83.4 pg/mL. A total of 141 glands were resected (95 adenomas, 33 hyperplasias). The subtypes were 57% classic, 32.2% normohormonal, and 10.7% normocalcemic. MGD occurred in 23.5% of patients divided as 13%, 30%, and 64% respectively (p = 0.0011). The surgical cure rate was 85.2%. The normocalcemic form had lower cure rate than the normohormonal (45% vs 84%, p = 0.018) and classic forms (45% vs 93%, p = 0.0006). MIBI scintigraphy identified at least one abnormal lesion, later confirmed by the pathologist in 90/98 patients, making the sensitivity per patient 91.8% (95% CI 84.1-96.2%).
MGD is strongly associated with mild pHPT, especially the normocalcemic form where it accounts for 64% of cases. Bilateral neck exploration should be performed in this population to improve the cure rate, even if the scintigraphy shows a single focus.
轻度原发性甲状旁腺功能亢进症(血清钙≤2.85mmol/L)是目前 pHPT 最具代表性的形式。本研究的目的是评估其亚型和多腺体疾病(MGD)发生率,因为这可能会降低术前甲状旁腺闪烁显像的敏感性和手术治愈率。
我们回顾性纳入了 2013 年 1 月至 2015 年 12 月期间接受过 Tc-MIBI SPECT/CT 甲状旁腺双示踪扫描并接受手术的轻度 pHPT 患者。治愈定义为术后 6 个月血清钙(或正常血钙患者的 PTH)正常。MGD 通过切除至少一个异常腺体后仍存在疾病或切除的两个腺体均异常来定义。
我们共纳入 121 例患者。术前血清钙中位数为 2.68mmol/L,PTH 中位数为 83.4pg/mL。共切除 141 个腺体(95 个腺瘤,33 个增生)。亚型为 57%经典型、32.2%无功能型和 10.7%正常血钙型。MGD 发生率为 23.5%,分别为 13%、30%和 64%(p=0.0011)。手术治愈率为 85.2%。正常血钙型的治愈率低于无功能型(45%比 84%,p=0.018)和经典型(45%比 93%,p=0.0006)。MIBI 闪烁显像至少能识别出一个异常病灶,随后在 98 例患者中有 90 例得到病理学家的证实,因此每位患者的敏感性为 91.8%(95%CI 84.1-96.2%)。
MGD 与轻度 pHPT 密切相关,尤其是正常血钙型,占 64%。即使闪烁显像显示为单个病灶,此类人群也应进行双侧颈部探查以提高治愈率。